Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Tourmaline Bio (TRML)

Annual Return

Over the past 3 years, TRML has had an average annual return of +29.28%, outperforming the benchmark SPY, which returned +22.45% annual.

Over the past 5 years, TRML has had an average annual return of -20.42%, underperforming the benchmark SPY, which returned +13.88% annual.

Since May 7, 2021, TRML has had an average annual return of -19.32%, underperforming the benchmark SPY, which returned +13.64% annual.

202620252024202320222021
+0%+136.59%-22.56%+192.20%-93.33%-5.91%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+0%+0%+0%+0%+0%+0%
2025-20.83%-18.49%+16.25%+13.13%-3.07%-4.19%+38.48%+5.74%+104.39%+0.30%+136.59%
2024+27.52%+16.24%-40.99%-30.90%-12.98%-6.63%+31.30%-0.17%+52.58%-0.78%+2.07%-22.14%-22.56%
2023+42.99%+32.96%-3.10%+53.15%-7.96%+14.71%-2.99%-2.37%-2.43%-33.14%+13.67%+39.65%+192.20%
2022-38.33%-25.66%+40.36%-28.24%+21.93%-47.62%-1.33%-25.60%-20.57%-42.58%-3.34%-30.07%-93.33%
2021-1.11%-8.59%-6.00%-15.92%+16.79%+24.55%-23.27%+17.98%-5.91%

Drawdown analysis of Tourmaline Bio (TRML)

The maximum drawdown for the TRML was -94.97%, occurring on Dec 28, 2022. This drawdown has not yet recovered.

The current TRML drawdown is -70.64%.

Since May 7, 2021 TRML has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 2 times
  • 10% or more: 2 times
DepthStartTo BottomBottomTo RecoverEndTotal
-94.97%Jun 7, 2021394Dec 28, 2022OngoingOngoingOngoing
-24.62%May 7, 20218May 19, 20218Jun 1, 202116
-0.29%Jun 2, 20211Jun 3, 20211Jun 4, 20212